Brief: BioRestorative Therapies Announces Completion Of Patient Enrollment For Safety Run-In Component Of Its Phase 2 Clinical Study Of BRTX-100

Biorestorative Therapies

24/04/2023 12:32

April 24 (Reuters) - BioRestorative Therapies Inc
 BRTX.O :
    * BIORESTORATIVE THERAPIES ANNOUNCES COMPLETION OF PATIENT
ENROLLMENT FOR SAFETY RUN-IN COMPONENT OF ITS PHASE 2 CLINICAL
STUDY OF BRTX-100
    * BIORESTORATIVE THERAPIES INC - BRTX-100 IS CURRENTLY BEING
EVALUATED IN CONNECTION WITH A PHASE 2 CLINICAL TRIAL TO TREAT
CLDD
    * BIORESTORATIVE THERAPIES INC - BRTX-100 TRIAL IS
PROSPECTIVE,
RANDOMIZED, DOUBLE-BLINDED AND CONTROLLED
    * BIORESTORATIVE THERAPIES INC - TRIAL WILL EVALUATE SAFETY
AND
PRELIMINARY EFFICACY OF A SINGLE DOSE OF BRTX-100

Source text for Eikon:  ID:nGNXcTzMG 
Further company coverage:  BRTX.O